相似文献
1
Diagnosis and office-based treatment of urinary incontinence in adults. Part one: diagnosis and testing.
Ther Adv Urol. 2013 Aug;5(4):181-7. doi: 10.1177/1756287213489720.
2
Diagnosis and office-based treatment of urinary incontinence in adults. Part two: treatment.
Ther Adv Urol. 2013 Aug;5(4):189-200. doi: 10.1177/1756287213495100.
3
What type of urinary incontinence does this woman have?
JAMA. 2008 Mar 26;299(12):1446-56. doi: 10.1001/jama.299.12.1446.
4
Urinary incontinence-assessment in women: stress, urge or both?
Aust Fam Physician. 2008 Mar;37(3):112-7.
5
Prevention of urinary and fecal incontinence in adults.
Evid Rep Technol Assess (Full Rep). 2007 Dec(161):1-379.
6
Urinary incontinence in older adults.
Mt Sinai J Med. 2011 Jul-Aug;78(4):558-70. doi: 10.1002/msj.20276.
7
Midurethral slings for women with stress urinary incontinence: an evidence-based analysis.
Ont Health Technol Assess Ser. 2006;6(3):1-61. Epub 2006 Feb 1.
8
Urinary incontinence in the elderly. Often simple to treat when properly evaluated.
Postgrad Med. 1995 May;97(5):109-16, 121.
9
Screening for Urinary Incontinence in Women: A Systematic Review for the Women's Preventive Services Initiative.
Ann Intern Med. 2018 Sep 4;169(5):311-319. doi: 10.7326/M18-0225. Epub 2018 Aug 14.
10
[Diagnostic value of patient history and physical examination in elderly patients with urinary incontinence; a literature review].
Ned Tijdschr Geneeskd. 2006 Aug 12;150(32):1771-5.
引用本文的文献
1
Expanding our understanding of lower urinary tract symptoms and incontinence in adults with pompe disease.
JIMD Rep. 2015;20:5-10. doi: 10.1007/8904_2014_381. Epub 2015 Jan 23.
2
The role(s) of cytokines/chemokines in urinary bladder inflammation and dysfunction.
Biomed Res Int. 2014;2014:120525. doi: 10.1155/2014/120525. Epub 2014 Mar 12.
本文引用的文献
1
Objective Evaluation of Overactive Bladder: Which Surveys Should I Use?
Curr Bladder Dysfunct Rep. 2013 Mar 1;8(1):45-50. doi: 10.1007/s11884-012-0167-2.
2
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence.
Neurourol Urodyn. 2010;29(1):213-40. doi: 10.1002/nau.20870.
3
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.
Neurourol Urodyn. 2010;29(1):4-20. doi: 10.1002/nau.20798.
4
Prevalence of symptomatic pelvic floor disorders in US women.
JAMA. 2008 Sep 17;300(11):1311-6. doi: 10.1001/jama.300.11.1311.
5
Urinary incontinence in women: variation in prevalence estimates and risk factors.
Obstet Gynecol. 2008 Feb;111(2 Pt 1):324-31. doi: 10.1097/01.AOG.0000267220.48987.17.
6
Differences in urinary incontinence between Hispanic and non-Hispanic white women: a population-based study.
BJU Int. 2008 Mar;101(5):575-9. doi: 10.1111/j.1464-410X.2007.07333.x. Epub 2008 Jan 8.
7
The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination survey.
J Urol. 2006 Nov;176(5):2103-8; discussion 2108. doi: 10.1016/j.juro.2006.07.029.
8
Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
Obstet Gynecol. 2006 Oct;108(4):855-62. doi: 10.1097/01.AOG.0000236446.17153.21.
9
Treatment of overactive bladder and incontinence in the elderly.
Rev Urol. 2002;4 Suppl 4(Suppl 4):S38-43.
10
The "costs" of urinary incontinence for women.
Obstet Gynecol. 2006 Apr;107(4):908-16. doi: 10.1097/01.AOG.0000206213.48334.09.
Zotero 插件